Bristol melanoma drug combo marks new advance in immunotherapy

[riky]

Bristol melanoma drug combo marks new advance in immunotherapy

By Julie Steenhuysen CHICAGO (Reuters) - Melanoma patients treated with two Bristol-Myers Squibb drugs fared much better than those who received either of the medications individually, a new advance for treatments that harness the body's immune system to fight cancer. Bristol released preliminary data from the early-stage trial on Wednesday, with more detailed results expected to highlight the American Society of Clinical Oncology's annual meeting in Chicago that starts at the end of the month. ...

Source: You are not allowed to view links. Register or Login